Year: 2026
Type: article
Abstract: LUPUS ERYTHEMATOSUS (LE) is an autoimmune connective tissue disease with a wide range of skin (cutaneous lupus erythematosus [CLE]) and/or systemic (systemic lupus erythematosus [SLE]) manifestations.Cutaneous involvement is found in up to 80% of patients with SLE,1 and CLE is observed as an initial manifestation of SLE in 0-42% of cases.2LE skin changes are divided into LEspecific (acute CLE, subacute CLE, chronic CLE) and LE-nonspecific (vascular and nonvascular signs) subtypes.3Some of these are more likely to lead to scarring (chronic CLE), but others have a higher risk of progression to SLE (acute CLE, subacute CLE).4
Source: EMJ Dermatology
Author: Guleva
Institution: Military Medical Academy
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7225868644
